Kolexia
Attarian Shahram
Neurologie
Hôpital La Timone
Marseille, France
373 Activités
168 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie de Charcot-Marie-Tooth Dystrophie musculaire facio-scapulo-humérale Sclérose latérale amyotrophique Maladies des dents Maladies musculaires Neuropathies périphériques Maladies neuromusculaires Maladies du motoneurone Syndrome de Guillain-Barré

Industries

LFB
17 collaboration(s)
Dernière en 2023
Sanofi
17 collaboration(s)
Dernière en 2023
Amicus Therapeutics
16 collaboration(s)
Dernière en 2023
Pfizer
11 collaboration(s)
Dernière en 2023

Dernières activités

Multidisciplinary team meetings in treatment of spinal muscular atrophy adult patients: a real-life observatory for innovative treatments.
Orphanet journal of rare diseases   24 janvier 2024
MITOMICS: Interest of Multi-omics (WES / RNA-Seq) Approach to Fight Against the Diagnostic Deadlock in Mitochondrial Diseases
Essai Clinique (CHU Nice)   11 janvier 2024
Objective evaluation of clinical actionability for genes involved in myopathies: 63 genes with a medical value for patient care
Abstracts from the 56th European Society of Human Genetics (ESHG) Conference   01 janvier 2024
Post-hoc Nonparametric Analysis of Forced Vital Capacity in the COMET Trial Demonstrates Superiority of Avalglucosidase Alfa vs Alglucosidase Alfa.
Journal of neuromuscular diseases   27 décembre 2023
Reply to letter on What biological markers could be used for diagnosis and monitoring of nitrous oxide abuse.
European journal of neurology   20 décembre 2023
Association of Plasma Creatinine Phosphokinase Elevation and a History of Idiopathic Cardiomyopathy in Heart Transplant Recipients.
The American journal of cardiology   16 décembre 2023
Retrospective clinical and genetic analysis of COL6-RD patients with a long-term follow-up at a single French center.
Frontiers in genetics   13 décembre 2023
The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Participants Who Have Already Been Treated With ALN-TTR02 (Patisiran): A Multicenter, Open-Label, Extension Study to Evaluate the Long-term Safety and Efficacy of Patisiran in Patients With Familial Amyloidotic Polyneuropathy Who Have Completed a Prior Patisiran Clinical Study
Essai Clinique (Alnylam)   05 décembre 2023
Dépistage génétique néonatal : à propos du programme pilote sur l’amyotrophie spinale (DEPISMA)
Bulletin de l'Academie nationale de medecine   30 novembre 2023
Clinical, biological, electrophysiological and therapeutic profile of patients with anti-MAG neuropathy according to MYD88 and CXCR4 mutations and underlying haemopathy.
Journal of neurology   18 novembre 2023